Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Remote app monitoring for people with chronic heart failure

Official title: EVOLVING AZIMUTH IN MUSA CONTEXT

Run by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT07022067 · Data updated 2026-11-12

It will test whether using a smartphone telemonitoring app for people with chronic heart failure to report blood pressure and body weight helps support care and detect problems earlier.

More Heart Failure trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment184 (estimated)
SponsorFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Academic / other
Locations1 site (Milan, Italy)
StatusRecruiting
StartedOctober 2, 2024
Main results expectedJune 30, 2025
Study endsAugust 31, 2025
Registry record updatedJune 15, 2025
Trial IDNCT07022067 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with chronic heart failure per ESC guidelines who have had recent hospital/ER access, can consent, own a compatible smartphone, and have home Wi‑Fi or mobile data are ideal candidates.

Probably not a fit

Patients with severe psychiatric disorders, inability or unwillingness to use portable technologies or the provided equipment, or those without a compatible smartphone or internet access are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with chronic heart failure are randomized to an experimental arm that downloads and uses a telemonitoring app to enter blood pressure and weight data, or to a control arm without the app. The hospital clinical team reviews submitted data via a platform and both groups complete questionnaires at enrollment, three months, and six months. The trial focuses on non‑pharmacological impacts, explicitly measuring positive effects (co‑creation) and negative effects (co‑destruction) of the telemonitoring service. Outcomes combine patient‑reported measures and process metrics related to remote monitoring and care interaction.

Why it matters

Potential benefit: If successful, the intervention could improve remote disease tracking, prompt earlier clinical responses, and help patients better self‑manage symptoms.

How similar studies have gone: Similar telemonitoring approaches for heart failure have produced mixed but promising results, with some trials reducing hospitalizations while others showed limited effect.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Have been diagnosed with chronic CS according to the ESC guidelines;
* Over 18 years of age;
* Patients admitted to hospital or with access to first aid within the last year;
* Smartphome that meets the digital requirements (ie Android or iOS able to download and use the application);
* Wi-Fi or 3G coverage at home;
* Ability to give written informed consent.

Exclusion Criteria:

* Severe psychiatric disorder
* Inability to use portable technologies
* Patients unable to use the equipment provided
* Patients who deny consent to study participation

Where it's running

  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
    Milan, Italy, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • MyHeartSentinel wearable system for remote heart monitoring

    This project will test whether wearing the MyHeartSentinel cutaneous device can record electrical and mechanical heart signals in adults hospitalized with decompensated chronic heart failure to help track changes in their condition.

    Recruiting University Hospital, Caen · Caen · NCT07345533

  • Using Apple Watch data to predict heart failure outcomes

    This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.

    Recruiting University Medical Center Goettingen · Goettigen, Lower Saxony · NCT06819618

  • Comparing Aortix Device to Diuretics for Acute Heart Failure

    This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.

    Recruiting at 33 sites Procyrion · Phoenix, Arizona and 49 other locations · NCT05677100

  • Research on health inequality and genetic disparity in cardiovascular diseases

    This study is trying to understand how health differences and genetics affect heart diseases in people from various ethnic backgrounds in the UK to help improve treatments for everyone.

    Recruiting Future Genetics Limited · Wolverhampton, West Midlands · NCT03987633

  • Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS

    Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.

    Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital · Beijing · NCT07912086

  • Tailored digital support to cut sedentary time in long-term cardiac rehab

    In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.

    Recruiting University of Lisbon · Lisbon, Lisbon District · NCT07910812

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.